Singapore markets open in 1 minute

Cytek Biosciences, Inc. (CTKB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.20-0.07 (-1.12%)
At close: 04:00PM EDT
6.08 -0.12 (-1.94%)
After hours: 07:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 823.03M
Enterprise value 574.75M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.39
Price/book (mrq)2.09
Enterprise value/revenue 2.86
Enterprise value/EBITDA -146.10

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-22.78%
S&P500 52-week change 325.59%
52-week high 39.87
52-week low 33.80
50-day moving average 36.62
200-day moving average 37.13

Share statistics

Avg vol (3-month) 3719.6k
Avg vol (10-day) 3601.04k
Shares outstanding 5131.26M
Implied shares outstanding 6131.26M
Float 8106.2M
% held by insiders 18.71%
% held by institutions 165.03%
Shares short (15 Apr 2024) 47.47M
Short ratio (15 Apr 2024) 410.02
Short % of float (15 Apr 2024) 47.29%
Short % of shares outstanding (15 Apr 2024) 45.69%
Shares short (prior month 15 Mar 2024) 48.51M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -5.73%
Operating margin (ttm)-23.93%

Management effectiveness

Return on assets (ttm)-3.06%
Return on equity (ttm)-2.82%

Income statement

Revenue (ttm)200.79M
Revenue per share (ttm)1.50
Quarterly revenue growth (yoy)21.00%
Gross profit (ttm)N/A
EBITDA -18.36M
Net income avi to common (ttm)-11.51M
Diluted EPS (ttm)-0.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)270.09M
Total cash per share (mrq)2.06
Total debt (mrq)10.17M
Total debt/equity (mrq)2.59%
Current ratio (mrq)6.99
Book value per share (mrq)2.99

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A